—#181058

Product

DFINE Vertebral Hydraulic Assemblies: Hydraulic Assembly, StabiliT Vertebral Augmentation System, Reference/Catalog number 1402 - Product Usage: is intended for percutaneous delivery of StabiliT ER2 Bone Cement in kyphoplasty procedures in the treatment of pathological fractures of the vertebrae. Painful vertebral compression fractures may result from osteoporosis, benign lesions (hemangioma), and malignant lesions (metastatic cancers, myeloma).

FDA product code: OAR — Injector, Vertebroplasty (Does Not Contain Cement)
Device class: Class 1
Medical specialty: Orthopedic
Affected lot / code info: Lot number: AAD-1801-16 and UDI: (01)00884450374399(17)221231(10)AAD-1801-16; Lot number: AAD-1801-17 and UDI: (01)00884450374399(17)221231(10)AAD-1801-17; Lot number: AAD-1803-01 and UDI: (01)00884450374399(17)230331(10)AAD-1803-01; Lot number: AAD-1804-05 and UDI: (01)00884450374399(17)230430(10)AAD-1804-05; Lot number: AAD-1901-07 and UDI: (01)00884450374399(17)231231(10)AAD-1901-07; Lot number: AAD-1904-04 and UDI: (01)00884450374399(17)240430(10)AAD-1904-04.

Why it was recalled

Vertebral hydraulic assemblies has incorrect expiration date printed on the labels.The product's shelf-life is two (2) years, but the expiration date printed on the labels is five (5) years.The affected product will begin expiring in March 2020. Using product beyond the validated shelf-life may result in (1) product not functioning as intended and/or (2) a delay in procedure or the need for the procedure to be rescheduled.

Root cause (FDA determination)

Labeling Change Control

Action the firm took

On 02/13/2020, the firm notified affected customers using a written notice titled, "URGENT PRODUCT RECALL NOTICE". The letter indicated: (1) Please immediately determine if any of the devices identified in the attached Customer Response Form (CRF) are within your facility, quarantine them, and discontinue use and distribution. (2) Ensure that applicable personnel within your organization are made aware of this field action. (3) If the product has been further distributed to other facilities, institutions, or manufacturers, please ensure this notice is immediately shared with them and note the quantity distributed on the CRF. Additional distribution details may be required by health authorities. (4) Please fill out, scan and email the completed Customer Response Form to Customer Service at response email address indicated in the letter. All affected product shipped to you must be accounted for on the CRF. (5) Please immediately return all affected lots in your possession via Federal Express 2nd Day Air using the account number provided in the letter. Please include a copy of the Customer Response Form with the returning product, reference the assigned RMA number on the outside of the box (see Customer Response Form), and ship to ATTN: Receiving & Customer Service at the firm's address listed in the letter. If you have any questions concerning this communication, please don't hesitate to contact your Sales Representative or Customer Service at (801) 208-4381.

Recalling firm

Firm: Merit Medical Systems, Inc.
Address: 1600 W Merit Pkwy South, Jordan, Utah 84095-2416

Distribution

Distribution pattern: Worldwide distribution: US Nationwide distribution including in the states of (TX, UT, PA, KY, TX, AR, CA, and PA) which included one (1) government/military consignee in KY; and the countries of (Germany, Switzerland, and New Zealand).

Timeline

Recall initiated: 2020-02-13
Terminated: 2021-02-26
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #181058. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.